Cryomass Technologies Inc (AFCT) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access AFCT Annual Cash Flow →
Changes in quarterly cash flow trends offer perspective on how Cryomass Technologies Inc funds operations, investments, and shareholder returns.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2024)
9 Months
(Jun 30 2024) (Mar 31 2024) (Sep 30 2023) (Jun 30 2023)
Operating Activities
Income-5.28
Depreciation & amortization0.09
Amortization of Other Assets0.09
Increase (Decrease) in Deferred Revenue0.00
Goodwill, Impairment Loss0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
Research and Development in Process0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.60
Bad Debt Expenses-
Prepaid Expenses-
Stockbased Compensation Expense-
Fair Value Of Common Stock Issued Pursuant To Service And Advisory Agreements-
Common Stock Issued For Vested R S Us For Current Period Service-
Goodwill And Intangible Asset Impairment-
Gain Losson Contingent Royalty Liability1.49
Stock Options Issued For Current Period Services0.10
Common Stock Issued For The Current Period Services-
Increase Decrease In Contract With Customer Liability0.93
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities1.31
Accrued Expense0.00
Payments for (Proceeds from) Other Deposits0.00
Increase (Decrease) in Prepaid Expense-0.01
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.13
Discontinued operations0.00
Net Cash flow from Operating Activities-0.55
Investing Activities
Capital Expenditures-0.10
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payoff Of Cryo Cann Loan Agreement At Closing-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Payments to Acquire Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Payments to Acquire Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.10
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.78
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Common Stock Subscribed-
Equity Issuance Costs-
Proceeds From Common Stock Subscribed And To Be Issued-
Proceeds From Loans Payable-
Proceeds From Notes Payable Current-
Repaymentofloanspayablecurrent-
Repayment Of Notes Payable Related Parties-
Principalinkind Interest Accrued-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.78
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.65
Total Cash Flow0.13
4 historic quarters locked

Sign in to unlock the full Cryomass Technologies Inc cash flow history.

About Cryomass Technologies Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001213900-24-095916

Figures are derived from filed reports and may be restated. Historical data is subject to revision.